Michael Link
Academic Appointments
- Professor, Pediatrics - Hematology & Oncology
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Pediatric Hematology/Oncology 2516 Stockton Blvd Ticon II Building Sacramento, CA 95817 Tel Work (650) 497-8953 Fax (650) 497-8101Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5535Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Pediatric Hematology-Oncology
Administrative Appointments
- President, American Society of Clinical Oncology (2011 - 2012)
- President-Elect, American Society of Clinical Oncology (2010 - 2011)
- Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - present)
- Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - 2010)
- Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - 2010)
Honors and Awards
- Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
- Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
- Alpha Omega Alpha, Alpha Omega Alpha (1974)
- Phi Beta Kappa, Phi Beta Kappa (1969)
Professional Education
| Fellowship: | Children's Hospital Boston MA (1979) |
| Residency: | Children's Hospital Boston MA (1976) |
| Internship: | Children's Hospital Boston MA (1975) |
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (1980) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1979) |
Scientific Focus
Current Research Interests
Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical Trials
- Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin's Disease Recruiting
- Reduced Duration Standford V Chemotherapy With Low-Dose Tailored-Field Radiation For Favorable Risk Pediatric Hodgkin Lymphoma Recruiting
- A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma No longer recruiting
- School Response to Families Who Have Children With Cancer Not yet recruiting
- Therapy for Pediatric Hodgkin Lymphoma No longer recruiting
Publications
- Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions. J Clin Oncol. 2012
- Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol. 2010; (7): 1232-9
- The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. J Clin Oncol. 2009; (24): 4014-20
- Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Appl Immunohistochem Mol Morphol. 2008; (2): 196-201
- Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007; (3): 332-7
Help
Trial Administration